A multicenter phase II study of bendamustine, rituximab, and cytarabine (BRAC) for relapsed or refractory patients with follicular lymphoma or mantle cell lymphoma #lymphoma #lymsm https://t.co/QUV7UaWVO3
2,454 followers
2,454 followers
A multicenter phase II study of bendamustine, rituximab, and cytarabine (BRAC) for relapsed or refractory patients with follicular lymphoma or mantle cell lymphoma #lymphoma #lymsm https://t.co/VxF9IsmZ4T
773 followers
RT @Lymphoma_Papers: A multicenter phase II study of bendamustine, rituximab, and cytarabine (BRAC) for relapsed or refractory patients wit…
1,199 followers
RT @Lymphoma_Papers: A multicenter phase II study of bendamustine, rituximab, and cytarabine (BRAC) for relapsed or refractory patients wit…